Lista de obras -

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics

artículo científico publicado en 2014

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.

artículo científico publicado en 2018

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

scientific article published on February 2014

Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity

artículo científico publicado en 2010

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials

artículo científico publicado en 2011

FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder

artículo científico publicado en 2013

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

artículo científico publicado en 2010

Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers

artículo científico publicado en 2009

Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression

artículo científico publicado en 2008

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer

artículo científico publicado en 2012

Gene set analysis of purine and pyrimidine antimetabolites cancer therapies

artículo científico publicado en 2011

Genetic association studies of copy-number variation: should assignment of copy number states precede testing?

artículo científico publicado en 2012

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study

artículo científico publicado en 2012

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system

scientific article published on 30 August 2013

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

artículo científico publicado en 2010

Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release

artículo científico

Identification of a novel percent mammographic density locus at 12q24.

artículo científico publicado en 2012

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

artículo científico publicado en 2017

Integrative gene set analysis: application to platinum pharmacogenomics

artículo científico publicado en 2013

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

artículo científico publicado en 2012

Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines

artículo científico publicado en 2016

Multivariate generalized linear model for genetic pleiotropy.

artículo científico publicado en 2017

Mycophenolic acid response biomarkers: A cell line model system-based genome-wide screen ⬇️

artículo científico publicado el 23 de marzo de 2011

Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics

artículo científico publicado en 2008

Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines

artículo científico publicado en 2010

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

artículo científico publicado en 2017

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention

artículo científico publicado en 2013

Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis

artículo científico publicado en 2012

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

artículo científico publicado en 2013

Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes

artículo científico publicado en 2014

Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders

scholarly article published 10 March 2018

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

artículo científico publicado en 2010

Lista de obras de

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials

FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers

Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer

Gene set analysis of purine and pyrimidine antimetabolites cancer therapies

Genetic association studies of copy-number variation: should assignment of copy number states precede testing?

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release

Identification of a novel percent mammographic density locus at 12q24.

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

Integrative gene set analysis: application to platinum pharmacogenomics

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines

Multivariate generalized linear model for genetic pleiotropy.

Mycophenolic acid response biomarkers: A cell line model system-based genome-wide screen ⬇️

Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics

Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention

Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes

Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer